Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Email from Matthew Perraton

<< Previous

Bullboard Posts

Next >>

Comment by tdon1229on Jan 07, 2024 8:19pm

204 Views

Post# 35814928

RE:RE:RE:RE:RE:RE:Email from Matthew Perraton

Harvard University Dana Farber Institute study (2015) shows
1. Nicotine is not addictive (it's the pyrazines the tobacco companies added)
2. Nicotine is efficacious vs. GBM in mice and rats, and likely in humans.

Nicotine occurs naturally in nightshade vegetables (eggplant, potatoes, etc.) and can't be patented, so Big Pharma can't make big money off it. As God has revealed in the Bible, he gave us everything we need. It's up to us to find it.

Do your own DD.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles